Monday, April 03, 2023 1:45:12 PM
Recent ARTL News
- Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia • GlobeNewswire Inc. • 12/09/2024 02:15:00 PM
- Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit • GlobeNewswire Inc. • 11/18/2024 01:30:00 PM
- Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium • GlobeNewswire Inc. • 11/13/2024 01:30:00 PM
- Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/08/2024 09:31:36 PM
- Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program • GlobeNewswire Inc. • 11/05/2024 01:30:00 PM
- Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th • GlobeNewswire Inc. • 10/09/2024 01:00:00 PM
- Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:00:00 PM
- Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor • GlobeNewswire Inc. • 07/15/2024 12:30:00 PM
- Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/03/2024 01:00:00 PM
- Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform • GlobeNewswire Inc. • 07/02/2024 01:00:00 PM
- Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium • GlobeNewswire Inc. • 07/01/2024 01:00:00 PM
- Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society • GlobeNewswire Inc. • 06/04/2024 12:30:00 PM
- Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24 • GlobeNewswire Inc. • 05/29/2024 12:30:00 PM
- Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th • GlobeNewswire Inc. • 05/10/2024 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge • GlobeNewswire Inc. • 03/12/2024 01:15:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy • GlobeNewswire Inc. • 01/23/2024 01:30:00 PM
- Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 • GlobeNewswire Inc. • 01/08/2024 01:30:00 PM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM
Consumer Automotive Finance, Inc. Announces Cancellation of 200 Million Common Shares and Updates on Name and Ticker Symbol Change • CAFI • Dec 6, 2024 12:45 PM
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA • CATV • Dec 6, 2024 8:00 AM
Bantec's Howco Distributing Co. and Bantec Environmental Corp. Win Contracts • BANT • Dec 5, 2024 10:00 AM